Seattle, WA, United States of America

Impel Neuropharma, Inc.


USPTO Granted Patents = 10


Trademarks = 5

Forward Citations = 24

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal John D Hoekman (10 out of 21 patents)

silverMedal Alan Brunelle (7 out of 12 patents)

bronzeMedal Michael Hite (5 out of 14 patents)

4 Joel Relethford (5 out of 7 patents)

5 Christopher William Fuller (4 out of 9 patents)

6 Craig Frederick Kohring (3 out of 8 patents)

7 Kelsey H Satterly (2 out of 5 patents)

8 Rodney J Y Ho (2 out of 10 patents)

9 Inna Dashevsky (1 out of 4 patents)

10 Aditya R Das (1 out of 4 patents)

11 Scott Youmans (1 out of 11 patents)

12 Stephen B Shrewsbury (1 out of 8 patents)


10 patents:

Impel Neuropharma, Inc. is a clinical-stage biotechnology company focused on developing innovative therapies for central nervous system (CNS) disorders. The company's proprietary Precision Olfactory Delivery (POD) technology allows for targeted delivery of therapeutics to the brain through the olfactory region, offering potential improvements in efficacy and safety. Impel's pipeline includes treatments for migraine, Parkinson's disease, and other neurological conditions.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

10 Patents

#186 in Seattle, WA

#654 in Washington

#28,957 in US

#54,287 in the World

...
Seattle, WA, United States of America
Forward Citations = 24

12 inventors:

Please report any incorrect information to support@idiyas.com
Loading…